Delivery Order SPE2DB22D1202-SPE2DB24FVHZ7

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of PYLERA CAPSULE UU 120S. The contract has a ceiling value of $1,373.51 and a completion date of October 8, 2024. The contract is a firm fixed price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to various government...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,336.09, is for the delivery of PYLERA CAPSULE UU 120S medical products. The contract has an ultimate completion date of February 5, 2025 and was awarded on February 4, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PYLERA CAPSULE UU 120S, a pharmaceutical product, with a ceiling value of $11,312.79 and a period of performance through May 2, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PYLERA CAPSULE UU 120S. The $5,382.01 firm-fixed-price contract has an ultimate completion date of August 15, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of PYLERA CAPSULE UU 120S medical products. The contract has a ceiling value of $5,288.00 and is a firm fixed-price Delivery Order type contract with an ultimate completion date of April 21, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,957.98 firm fixed-price contract is for the supply of PYLERA CAPSULE (NDC 4567013660) and has an ultimate completion date of January 23, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare...
This federal contract award is for the delivery of PYLERA CAPSULE UU 120S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,664.49 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of PYLERA CAPSULE UU 120S, a pharmaceutical product, with a ceiling value of $2,736.99 and a completion date of April 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PYLERA CAPSULE UU 120S, a medical product, with a ceiling value of $3,280.81 and a period of performance ending on May 8, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,260.57 firm fixed-price delivery order is for the supply of 4560750056 - PYLERA CAPSULE UU 120S, with a completion date of April 28, 2023. The contract is not designated with a set-aside, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVHZ7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of PYLERA CAPSULES in quantities of 120 capsules per bottle. The contract has a ceiling value of $2,553.51 and is a firm fixed-price contract with a completion date of July 29, 2024. The contract is not set aside for any particular business category. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award, which is likely part of a larger indefinite delivery/indefinite quantity (ID/IQ) contract the company holds with DLA to provide a wide range of pharmaceutical products and medical supplies to support military treatment facilities and other government healthcare programs.

Generated 10/25/24, 9:26 AM